Beijing is built to the national project centre of new

Beijing is built to the national project centre of new vaccine
News from Beijing on June 30 ' Reporter Zheng JinWu) In the morning of June 29, the foundation stone laying ceremony of research center of national project of new vaccine is in Beijing (also village) Hold in the economic and technological development zone. It is reported, this centre is only national-level new vaccine researching and developing and engineered, industrialization base and service platform of the whole country that a national development and reform committee sets up. The main goal of the centre is to employ modern biotechnology, improve the great technological difficult problem in traditional vaccine and research and development and industrialization of solving new vaccine, engaged in new vaccine especially, histones serious, it is poly- medicine, core medicines sour, lasting the research and developments of biological medicineses such as reagent,etc. and in producing as a trial and technical consulting services biological,etc., offer the intact engineered and technological platform of industrialization for research and development of new vaccine of our country. XinLiang Shen, director of centre, reveal vaccine that centre this develop include the intersection of brothers and the intersection of mouth and the intersection of disease and vaccine, the intersection of hepatitis and the intersection of vaccine,etc. and several vaccine kinds at present, this centre also bore the construction of the national infectious disease emergency response system at the same time.

It is introduced, disparity and big that although there is disparity in vaccine research and development ability and world standard of our country at present, but more weak in vaccine industrialization. The national project research center of new vaccine will depend on rich technological capability and strong research and development ability, offer the industrialization achievement continually for the new vaccine industry of our country. Meanwhile, in should large prevail, to sudden infectious disease, until short time finish preventative or treatment reseach task of vaccine most, offer strong support for controlling the epidemic situation and spreading, ensuring health and social stability of people's life.

This centre will build 4 pilot production lines and comprehensive laboratories and relevant auxiliary facilities. Among them, viral vaccine (deactivate) The intersection of pilot and platform, viral vaccine ' Reduce the poison) Pilot platform, bacterial vaccine pilot platform, insect's cell pilot platform, five major pilot platforms of pilot platform of genetic engineering yeast have multiple international advanced technology and craft, can undertake engineered research and development and technical support of national or local relevant fields and projects.

It is reported, this centre has already been listed in national high-tech industry development project plan and national fund and has subsidized the plan, and joined and wrapped up the service alliance (ABO) outside China's biotechnology ; Meanwhile, bore multiple national great projects (mouth disease vaccine, first type influenza vaccine,etc. such as EV71 brothers) And " 863 " Key subject of the plan. In addition, the national project research center (raise) of new vaccine Have also launched extensive exchange and cooperation with many units both at home and abroad.

Beijing Vice Mayor's careless second document shows, Beijing will further devote more efforts to supporting, actively promote the fast development of the biological medicine industry, accelerate close combination and achievement of production, learning and research and transform the process, promote the health of whole trade and Beijing economy to develop continuously.

The floor area of project planning of this centre is about 22749 square meters, gross investment is about 209,470,000 yuans, the project plans to complete in an all-round way in December of 2010. This project regards little valley biological medicine Co., Ltd. of Beijing as and sets up carriers, from China biotechnology group company, the Temple of Heaven biologicals Limited Company, Beijing institute of biological products and Center for Disease Prevention and Control of China (CDC) Virosis is prevented and cotrolled and provided funds and set up together.

Beijing is built to the national project centre of new vaccine